Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Case ReportCase Report
Open Access

Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation

Huan Zhao, Min Shi, Fang Yang and Xuhong Yang
Neurosciences Journal April 2022, 27 (2) 111-115; DOI: https://doi.org/10.17712/nsj.2022.2.20210123
Huan Zhao
From the Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Shi
From the Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Yang
From the Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuhong Yang
From the Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

Kearns-Sayre Syndrome (KSS) is a subtype of chronic progressive external ophthalmoplegia (CPEO). In this case, A 21-year-old man diagnosed with KSS, and presented with chronic progressive blepharoptosis (ptosis) and external ophthalmoplegia, diffuse depigmentation of the retinal pigment epithelium, and cerebellar ataxia, with a cerebrospinal fluid protein of 254 mg/dL, was reported. Genetic screening revealed a novel mutated gene in SLC25A4 in the patient as well as in his mother: NM_001151:c.170G>C in exon 2. Its imaging finding is a characteristic progressive atrophy of the right cerebellar hemisphere. In conclusion, we found a case of KSS with a novel mutated gene in SLC25A4: NM_001151:c.170G>C in exon 2 as the pathogenic mechanism, and found that KSS can be caused only when the proportion of mutations in the SLC25A4 gene reach a certain degree, and the patient with KSS showed a unique cranial imaging feature of unilateral progressive cerebellar atrophy.

Kearns-Sayre Syndrome (KSS) is a subtype of chronic progressive external ophthalmoplegia (CPEO). The 3 main symptoms of KSS are onset before 20 years of age, CPEO, and pigmented retinopathy. At least one of the following symptoms is accompanied: complete heart block, cerebrospinal fluid protein greater than 100 mg/dL, cerebellar ataxia, short stature, deafness, dementia, and endocrine abnormality.1 Since Kearns and Sayre first reported KSS in 1958, there have been reports of mtDNA deletions at different locations and sizes in many patients.2 The most common deletion is marked as the “common 4977 bp deletion,” accounting for more than one-third of all cases.3-5 The central nervous system (CNS) involvement of the disease is reflected in the degree of MRI abnormalities, including hyperintensity of fluid-attenuated inversion recovery (FLAIR) sequence in the brainstem, globus pallidus, thalamus, and cerebral and cerebellar white matter. Here, we report a case of a 21-year-old man with KSS who had a novel mutated gene in SLC25A4: NM_001151:c.170G>C in exon 2 and had a special imaging finding of progressive atrophy of unilateral cerebellum.

Case Report

Patient information

The patient is 21-year-old male.

Diagnostic assessment

At the age of 13 years, parents of the patient brought him to a local children’s hospital due to a speech rate lower than that of a normal child, with no abnormality found on the children’s intelligence screening test. Cranial MRI revealed (A1 and C1 in Figure 1) obvious cerebellar vermian sulcus, and mild atrophy was not excluded. His symptom slowly worsened, and significantly worsened at the age of 16 years, specifically with significantly elongated speech, heterogeneous pitch, and often fulminant. He visited a local hospital and cranial MRI revealed (A2, B1 and C2 in Figure 1) revealed slight narrowing of the gyri in the right cerebellar hemisphere and mild atrophy of the right cerebellum, and the above symptoms gradually worsened. At the age of 19, the patient gradually developed right blepharoptosis, inability to move in the lower and right lower direction (Figure 3), and double vision, with significant elongated speech, heterogeneous pitch, and often fulminant. He visited our Neurology Department at the age of 21 (Table 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

- MRI images A1 and C1) are the cranial MRI images on May 14, 2011. They reveal obvious sulcus of vermis cerebelli; A2, B1 and C2) are the cranial MRI images on August 4, 2014. They reveal slight narrowing of the gyrus of the right cerebellar hemisphere; A3, B2 and C3) are the cranial MRI images on November 4, 2019. They reveal narrowing of the gyrus of the right cerebellar hemisphere and widening of the sulcus.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

- Outer retinal atrophy in the right eye revealed by OCT of both eyes in the Department of Ophthalmology of our hospital in November 2019.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

- The physical examination image A) November 1, 2019: both pupils are of the same size and roundness, with a diameter of about 3mm, sensitive to light reflex, blepharoptosis for the right, and mild restriction for movement in the downward and lower right directions; B) April 20, 2020: both pupils are of the same size and roundness, with a diameter of about 3 mm, sensitive to light reflex, blepharoptosis for the right, unable to move in the downward and lower right directions.

View this table:
  • View inline
  • View popup
Table 1

- Patient timeline.

Clinical findings

Results of laboratory test, electrophysiological examination, cerebrospinal fluid examination, ECG and other related examinations are provided in the table (Table 2). The OCT showed outer retinal atrophy in the right eye (Figure 2), cranial MRI showed significant atrophy of the right cerebellar hemisphere (A3, B2 and C3 in Figure 1), and cranial contrast-enhanced MRI did not show significant abnormalities. The test result of mitochondrial gene hotspot mutation in MELAS (mitochondrial encephalomyopathy) syndrome using PCR-Sanger was negative (Table 3). The result of copy number variation sequencing (CNV-Seq) using PCR-Sangers sequencing was negative, the test of mitochondrial disease-related nuclear genome using next-generation sequencing (NGS, whole exome sequencing analysis) showed that the patient carried the suspected pathogenic gene of SLC25A4. Then the first-generation sequencing for SLC25A4 gene was performed on his parents, and the results indicated that the NM_001151:c.170G>C heterozygous mutation of SLC25A4 gene occurred in the exon 2 region in both the patient and his mother. Quantitative polymerase chain reaction5 revealed that the patient had mitochondrial DNA deletion (mitochondrial/nuclear DNA: 18.7%) (mitochondria DNA depletion (mito-chondria/nuclear DNA: 18.7%)), and the patient’s mother had mitochondria DNA depletion (mitochondria/nuclear DNA: 2.7%). This study was approved by the Ethics Committee of the Affiliated Hospital of Chengdu University of TCM.

View this table:
  • View inline
  • View popup
Table 2

- Laboratory examination, electrophysiological examination, cerebrospinal fluid (CSF) examination and other examinations.

View this table:
  • View inline
  • View popup
Table 3

- Negative test result of mitochondrial gene hotspot mutation in MELAS (Mitochondrial Encephalomyopathy) syndrome using PCR-Sanger.

Therapeutic intervention

The patient received trophic nerve therapy during hospitalization.

Follow-up and outcomes

The symptoms were not significantly improved. After discharge, the patient continued to be followed up for about half a year by the outpatient department. The above symptoms continued to worsen, without other clinical symptoms.

Discussion

The KSS is very rare. Although the exact prevalence of this disease is unknown, a study reported a prevalence of 1.6 cases per 100,000 people in the Finnish population.5 In this report, the patient had onset at the age of 13, with the clinical manifestations of chronic progressive blepharoptosis (ptosis) and external ophthalmoplegia, diffuse depigmentation of the retinal pigment epithelium, cerebellar ataxia and cerebrospinal fluid protein of 254 mg/dL, and the clinical features were consistent with the diagnosis of KSS.

Genetic screening revealed a novel mutated gene in SLC25A4 in the patient as well as in his mother: NM_001151:c.170G>C in exon 2. Several mutations in SLC25A4 are associated with mitochondrial diseases and are divided into 2 different clinical phenotypes: null recessive mutations leading to mitochondrial myopathy and cardiomyopathy phenotypes, appearing in childhood or early adulthood and characterized by fatigue and exercise intolerance (also known as mitochondrial DNA depletion) (type of syndrome 12 [MIM: 615418])6,7 and the condition of pathogenic autosomal dominant progressive external ophthalmoplegia caused by several separate heterozygous mutations in adult (adPEO [MIM: Report 609283])5,7 but the NM_001151:c.170G>C mutation in exon 2 in SLC25A4 has never been reported, and in combination with the clinical manifestations of the patient and his mother, we found that mutations at this site do not necessarily cause the development of KSS, and Sanger sequencing reveals NM_001151.4: c.239G > a (p.a arg80his) heterozygous de novo mutation in SLC25A4. Quantitative polymerase chain reaction5 revealed that the patient had mitochondrial DNA deletion (mitochondrial/nuclear DNA: 18.7%) (mitochondria DNA depletion (mito-chondria/nuclear DNA: 18.7%)), and the patient’s mother had mitochondria DNA depletion (mitochondria/nuclear DNA: 2.7%). We speculate that KSS can be caused only when the proportion of mutations in the SLC25A4 gene reach a certain degree.

Postmortem neuropathology in KSS patients may sometimes be associated with severe demyelination of white matter tracts in the brain.5,7 Central nervous system (CNS) involvement is reflected in the degree of MRI abnormalities, including hyperintensity of fluid-attenuated inversion recovery (FLAIR) sequence in the brainstem, globus pallidus, thalamus, and cerebral and cerebellar white matter.7 But these findings were not seen in this patient, but rather a significant progressive atrophy of the right cerebellar hemisphere, which has not been reported in previous cases of KSS.

  • Received September 24, 2021.
  • Accepted February 1, 2022.
  • Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

References

  1. 1.↵
    1. Tsang SH,
    2. Aycinena ARP,
    3. Sharma T.
    Mitochondrial Disorder: Kearns-Sayre Syndrome. Adv Exp Med Biol 2018; 1085: 161–162.
    OpenUrl
  2. 2.↵
    1. Shemesh A,
    2. Margolin E.
    Kearns Sayre Syndrome.StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC., 2022.
  3. 3.↵
    1. Nguyen MTB,
    2. Micieli J,
    3. Margolin E.
    Teaching NeuroImages: Kearns-Sayre syndrome. Neurology 2019; 92: e519–e520.
    OpenUrl
  4. 4.
    1. Saldaña-Martínez A,
    2. Muñoz ML,
    3. Pérez-Ramírez G,
    4. Montiel-Sosa JF,
    5. Montoya J,
    6. Emperador S, et al.
    Whole sequence of the mitochondrial DNA genome of Kearns Sayre Syndrome patients: Identification of deletions and variants. Gene 2019; 688: 171–181.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Shimura M,
    2. Kuranobu N,
    3. Ogawa-Tominaga M,
    4. Akiyama N,
    5. Sugiyama Y,
    6. Ebihara T, et al.
    Clinical and molecular basis of hepatocerebral mitochondrial DNA depletion syndrome in Japan: evaluation of outcomes after liver transplantation. Orphanet J Rare Dis 2020; 15: 169.
    OpenUrl
  6. 6.↵
    1. Padhy SK,
    2. Kumar V,
    3. Mandal S.
    Pigmentary retinopathy in Kearns-Sayre syndrome. BMJ Case Rep 2018; 2018: bcr2018227394.
  7. 7.↵
    1. Trivedi M,
    2. Goldstein A,
    3. Arora G.
    Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome. Cardiol Young 2018; 28: 1487–1488.
    OpenUrl
PreviousNext
Back to top

In this issue

Neurosciences Journal: 27 (2)
Neurosciences Journal
Vol. 27, Issue 2
1 Apr 2022
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation
Huan Zhao, Min Shi, Fang Yang, Xuhong Yang
Neurosciences Journal Apr 2022, 27 (2) 111-115; DOI: 10.17712/nsj.2022.2.20210123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation
Huan Zhao, Min Shi, Fang Yang, Xuhong Yang
Neurosciences Journal Apr 2022, 27 (2) 111-115; DOI: 10.17712/nsj.2022.2.20210123
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cauda equina syndrome by extrusion of lumbar disc after lumbar sympathetic neurolysis
  • Post COVID-19 Guillain–Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure
  • Thrombosis of intraorbital arterio-venous fistula
Show more Case Report

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2023 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire